AMPK activation attenuates central sensitization in a recurrent nitroglycerin-induced chronic migraine mouse model by promoting microglial M2-type polarization.

MLA

Lu, Guangshuang, et al. “AMPK Activation Attenuates Central Sensitization in a Recurrent Nitroglycerin-Induced Chronic Migraine Mouse Model by Promoting Microglial M2-Type Polarization.” Journal of Headache & Pain, vol. 25, no. 1, Mar. 2024, pp. 1–18. EBSCOhost, https://doi.org/10.1186/s10194-024-01739-w.

APA

Lu, G., Xiao, S., Meng, F., Zhang, L., Chang, Y., Zhao, J., Gao, N., Su, W., Guo, X., Liu, Y., Li, C., Tang, W., Zou, L., Yu, S., & Liu, R. (2024). AMPK activation attenuates central sensitization in a recurrent nitroglycerin-induced chronic migraine mouse model by promoting microglial M2-type polarization. Journal of Headache & Pain, 25(1), 1–18. https://doi.org/10.1186/s10194-024-01739-w

Chicago

Lu, Guangshuang, Shaobo Xiao, Fanchao Meng, Leyi Zhang, Yan Chang, Jinjing Zhao, Nan Gao, et al. 2024. “AMPK Activation Attenuates Central Sensitization in a Recurrent Nitroglycerin-Induced Chronic Migraine Mouse Model by Promoting Microglial M2-Type Polarization.” Journal of Headache & Pain 25 (1): 1–18. doi:10.1186/s10194-024-01739-w.